Immune checkpoint inhibitors have shown efficacy in other HPV-related cancers, so a phase 2 trial tested the anti-PDL-1 antibody avelumab in patients with locally advanced or metastatic penile cancer ...

The researchers found that the risk for depression was higher among breast cancer survivors than controls (hazard ratio, 5.94). Insomnia (defined as ≥8 on the Insomnia Severity Index) further ...

Researchers evaluated long-term outcomes among patients with CML living in LMICs who received imatinib through financial assistance from the Max Foundation.

U03 trial tested novel pembrolizumab-based triplet regimens for first-line treatment of advanced clear cell renal cell carcinoma (ccRCC).

Alongside reducing body mass index, “physical activity may have systematic anticancer effect, such as improving insulin sensitivity, reducing hyperinsulinemia, lowering systemic inflammation, and ...

Researchers reported on a prediction model developed to determine which patients with spinal metastases were likely to benefit from surgery.

The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

Study researchers noted that the findings suggest the association between anxiety and improved OS was at least partly related to the higher incidence of irAEs, which implies that, in people with an ...

The treatment effects on PFS were consistent regardless of modeling approach and for both targeted and nontargeted therapies.

A review of EMR data from younger and older women with breast cancer noted that social support was not consistently documented among patients.

Funding accounted for 34.5 percent of total financial assistance requested in campaigns initiated between Jan. 1, 2021, and Feb. 28, 2023.

Results of the CheckMate 67T, a phase 3 noninferiority study comparing subcutaneous and intravenous nivolumab formulations in renal cell carcinoma, were presented at JADPRO 2025.